NM_002600.4:c.282-126331C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002600.4(PDE4B):c.282-126331C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0622 in 152,136 control chromosomes in the GnomAD database, including 436 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.062 ( 436 hom., cov: 32)
Consequence
PDE4B
NM_002600.4 intron
NM_002600.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.568
Publications
4 publications found
Genes affected
PDE4B (HGNC:8781): (phosphodiesterase 4B) This gene is a member of the type IV, cyclic AMP (cAMP)-specific, cyclic nucleotide phosphodiesterase (PDE) family. The encoded protein regulates the cellular concentrations of cyclic nucleotides and thereby play a role in signal transduction. Altered activity of this protein has been associated with schizophrenia and bipolar affective disorder. Alternative splicing and the use of alternative promoters results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.17 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PDE4B | NM_002600.4 | c.282-126331C>T | intron_variant | Intron 3 of 16 | ENST00000341517.9 | NP_002591.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PDE4B | ENST00000341517.9 | c.282-126331C>T | intron_variant | Intron 3 of 16 | 1 | NM_002600.4 | ENSP00000342637.4 |
Frequencies
GnomAD3 genomes AF: 0.0621 AC: 9444AN: 152018Hom.: 434 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
9444
AN:
152018
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0622 AC: 9466AN: 152136Hom.: 436 Cov.: 32 AF XY: 0.0615 AC XY: 4577AN XY: 74364 show subpopulations
GnomAD4 genome
AF:
AC:
9466
AN:
152136
Hom.:
Cov.:
32
AF XY:
AC XY:
4577
AN XY:
74364
show subpopulations
African (AFR)
AF:
AC:
745
AN:
41500
American (AMR)
AF:
AC:
1184
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
437
AN:
3470
East Asian (EAS)
AF:
AC:
21
AN:
5186
South Asian (SAS)
AF:
AC:
868
AN:
4812
European-Finnish (FIN)
AF:
AC:
362
AN:
10582
Middle Eastern (MID)
AF:
AC:
40
AN:
294
European-Non Finnish (NFE)
AF:
AC:
5555
AN:
67996
Other (OTH)
AF:
AC:
191
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
441
883
1324
1766
2207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
124
248
372
496
620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
357
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.